Skip to main content Help with accessibility Skip to main navigation

BISPHOSPHONATES, oral for treating osteoporosis

Last Updated: 24 October 2019

Body System: Musculoskeletal system


The Pan Mersey Area Prescribing Committee recommends the prescribing of ORAL BISPHOSPHONATES (alendronic acid, ibandronic acid and risedronate sodium) for treating osteoporosis in accordance with NICE TA464.